Aimed at academic institutions and students, “Boehringer Ingelheim: Leading Innovation” is a Teaching Case Study.
The case writers Professor J. Robert Mitchell, Ph.D., and Ramasastry Chandrasekhar, at Ivey Business School follow the footsteps of Stephan’s intrapreneurial approach to innovation from within a global pharmaceutical company (FORTUNE Global 500, Top 20 Pharma). This intrapreneurship teaching case study is used by staff and students of Intrapreneurship and Innovation in business schools around the world. It is available for download at Harvard Business Review (HBR) and Ivey Business School.
Teaching Institutions using this teaching case study include:
- Ivey Business School, University of Western Ontario in London, Ontario/Canada
- Colorado State University (CSU), Ford Collins/USA
- Foreign Trade University (FTU), Hanio/Vietnam
- IE – International University, Madrid/Spain
- National Chengchi University, Taipei/Taiwan
- Sobey School of Business, Saint Marys University, Halifax, Nova Scotia/Canada
Taking the entrepreneurial approach
(Marketing and Sales, Intrapreneurship)
Corporations can be so constrained by their hierarchy and mindset that they are unable to adapt to the rapidly changing commercial landscape. That’s when businesses need “intrapreneurs” and “angel investors”, Stephan Klaschka tells Nick de Cent. Eyeforpharma interview published 2015.
The Art of Innovation: How to Become a “Partner of Choice”
How can pharma companies ensure they’re first in line when researchers and entrepreneurs come knocking?
Eyeforpharma interview by Nick de Cent with Angel Pérez Agenjo (Lilly), Kemal Malik (Bayer), and Stephan Klaschka (former Boehringer Ingelheim) published 2016.
Calls Moving to Consults
How can the pharmaceutical industry re-skill representatives to become knowledgeable consultants to physicians?